Nano-X Imaging: Moshe Moalem reports 8.49% stake

Moalem says he intends to vote against a proposed increase in authorized ordinary shares at the November 18, 2026 special general meeting.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. is the issuer whose ordinary shares Moshe Moalem, identified as an entrepreneur and investor, reports beneficially owning 6,675,413 shares, or 8.49% of the class. He directly holds 5,678,682 shares and reports beneficial ownership of another 996,731 held by Tanir Corporation BVI, a company he wholly owns and controls. The issuer had 78,609,485 ordinary shares outstanding as of August 17, 2026.

Moalem says he intends to vote against a proposal to increase authorized ordinary shares from 150,000,000 to 450,000,000 at the special general meeting scheduled for November 18, 2026. He also intends to ask the issuer to refrain from issuing additional voting shares before the November 2, 2026 record date. He may pursue proposals including director nominations or proxy solicitation, subject to applicable law and the issuer’s organizational documents; he has not identified particular nominees.

Key Figures

Beneficially owned ordinary shares: 6,675,413 shares Percentage of class: 8.49% Directly held ordinary shares: 5,678,682 shares +3 more

6 metrics

Beneficially owned ordinary shares 6,675,413 shares Reported by Moshe Moalem

Percentage of class 8.49% Based on ordinary shares outstanding as of August 17, 2026

Directly held ordinary shares 5,678,682 shares Held directly by Moshe Moalem

Ordinary shares held by Tanir Corporation BVI 996,731 shares Tanir Corporation BVI is wholly owned and controlled by Moshe Moalem

Ordinary shares outstanding 78,609,485 shares As of August 17, 2026

Proposed authorized ordinary shares 150,000,000 to 450,000,000 shares Proposal for the special general meeting scheduled for November 18, 2026

Key Terms

beneficially own, Sole Voting Power, Sole Dispositive Power, record date, +1 more

5 terms

beneficially own financial

"may therefore be deemed to beneficially own such shares"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

Sole Voting Power regulatory

"Sole Voting Power 6,675,413.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power regulatory

"Sole Dispositive Power 6,675,413.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

record date regulatory

"before the November 2, 2026 record date"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

contested election of directors regulatory

"including through a contested election of directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NNOX shares does Moshe Moalem beneficially own?

Moshe Moalem reports beneficial ownership of 6,675,413 Nano-X Imaging ordinary shares, equal to 8.49% of the class. He directly holds 5,678,682 shares; another 996,731 are held by Tanir Corporation BVI, which he wholly owns and controls. The issuer had 78,609,485 ordinary shares outstanding as of August 17, 2026.

What does Moshe Moalem plan to do about the NNOX share-capital proposal?

Moalem says he intends to vote against increasing authorized ordinary shares from 150,000,000 to 450,000,000 at the special general meeting scheduled for November 18, 2026. He also intends to ask Nano-X Imaging to refrain from issuing additional voting shares before the November 2, 2026 record date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/29/2026 - 02:20 PM EDT Accepted by SEC EDGAR 10/29/2026 - 02:20 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Nano-X Imaging Ltd.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

M70700105

(CUSIP Number)

Moshe Moalem
8 Herzl Rosenblum Street,
Tel Aviv, L3, 6937952
0545884882

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

10/29/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): M70700105

1

Name of reporting person

Moalem Moshe

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF, OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 6,675,413.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 6,675,413.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

6,675,413.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

8.49 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

The percentage of the class in Item 11, is based upon 78,609,485 Ordinary Shares outstanding as of August 17, 2026, as reported in the Issuer's Proxy Statement for its Annual General Meeting attached as Exhibit 99.1 to its Current Report on Form 6K filed with the Securities and Exchange Commission on August 18, 2026

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Ordinary Shares
(b)	Name of Issuer: Nano-X Imaging Ltd.
(c)	Address of Issuer's Principal Executive Offices: Ofer Tech Park, 94 Shlomo Shmeltzer Road, Petach Tikva, ISRAEL , 4970602.
Item 2.	Identity and Background
(a)	Moshe Moalem
(b)	8, Herzl Rosenblum Street, Tel Aviv, Israel 6937952.
(c)	Entrepreneur and Investor 8, Herzl Rosenblum Street, Tel Aviv, Israel 6937952.
(d)	The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	The Reporting Person has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	The Reporting Person is an Israeli citizen.
Item 3.	Source and Amount of Funds or Other Consideration
	The Ordinary Shares beneficially owned by the Reporting Person were acquired prior to and following the Issuer's initial public offering, using personal funds or through other transactions. No additional Ordinary Shares were acquired in connection with the filing of this Schedule 13D. The percentage of the class in Item 11, is based upon 78,609,485 Ordinary Shares outstanding as of August 17, 2026, as reported in the Issuer's Proxy Statement for its Annual General Meeting attached as Exhibit 99.1 to its Current Report on Form 6K filed with the Securities and Exchange Commission on August 18, 2026.
Item 4.	Purpose of Transaction
	The Reporting Person acquired the Ordinary Shares beneficially owned by him for investment purposes and intends to review his investment in the Issuer on a continuing basis. The Reporting Person is dissatisfied with the Issuer's performance and the resulting impact on shareholder value. The Reporting Person intends to engage in discussions with the Issuer's management and Board of Directors (the "Board"), as well as other shareholders and interested parties, concerning the Issuer's business, operations, financial performance, strategy, management, corporate governance, Board composition and other matters relating to the Issuer. In particular, the Reporting Person opposes the proposed increase in the Issuer's authorized share capital from 150,000,000 to 450,000,000 Ordinary Shares described in the Issuer's proxy statement furnished to the Securities and Exchange Commission on October 28, 2026, for the special general meeting of shareholders scheduled for November 18, 2026. The Reporting Person is concerned about the scale of the proposed increase, its potential to facilitate substantial further dilution of existing shareholders, and the Issuer's financing strategy and capital allocation in light of its performance and the decline in the trading price of its Ordinary Shares. The Reporting Person currently intends to vote against that proposal and may communicate with the Issuer and other shareholders regarding his opposition. The Reporting Person also intends to request that the Issuer refrain from issuing additional voting shares before the November 2, 2026 record date for that meeting. The Reporting Person is concerned that an issuance immediately before the record date could materially alter the voting composition of the meeting and dilute existing shareholders' voting influence, particularly if accompanied by arrangements or economic incentives connected with approval of the proposals. The Reporting Person may seek information regarding any such issuance and any related arrangements and may consider appropriate legal action to protect shareholder rights. In connection with its communications with the Issuer, the Reporting Person may make recommendations or proposals concerning the Issuer's business, operations, strategy, management and corporate governance, including potential changes to the composition, size or leadership of the Board and/or the Issuer's management. The Reporting Person may also consider, propose, support or oppose the appointment, election or removal of directors, identify or recommend potential director candidates, nominate candidates for election to the Board, submit shareholder proposals, solicit proxies or otherwise seek shareholder support for any such actions, including through a contested election of directors, in each case subject to applicable law and the Issuer's organizational documents. The Reporting Person may communicate with other shareholders and interested parties regarding any of the foregoing matters and may consider coordinating or acting together with other shareholders in connection with potential actions concerning the Issuer, subject to applicable law. Depending on various factors, including the outcome of the discussions described above, the Issuer's financial condition, business, operations and prospects, actions taken by the Issuer's management and Board, market conditions and other factors that the Reporting Person may deem relevant, the Reporting Person may from time to time acquire additional securities of the Issuer, dispose of some or all of the securities beneficially owned by him, or consider, formulate or pursue plans or proposals relating to any of the matters described in paragraphs (a) through (j) of Item 4 of Schedule 13D. As of the date hereof, has not identified any particular candidates for nomination to the Board. Except as described herein, the Reporting Person has no present definitive plans or proposals relating to any of the matters described in paragraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Person reserves the right to review or reconsider his position and to formulate, modify or pursue plans or proposals with respect to any of the foregoing matters at any time, subject to applicable law.
Item 5.	Interest in Securities of the Issuer
(a)	(a) Aggregate Number and Percentage of the Class of Securities Identified6,675,413 ordinary shares. The Reporting Person directly holds 5,678,682 Ordinary Shares. An additional 996,731 Ordinary Shares are held by Tanir Corporation BVI, a company wholly owned and controlled by the Reporting Person. The Reporting Person possesses sole voting and dispositive power over the Ordinary Shares held by Tanir Corporation BVI and may therefore be deemed to beneficially own such shares.
(b)	(i) sole power to vote or to direct the vote: See Item 7 on the cover page(s) hereto. (ii) shared power to vote or to direct the vote: See Item 8 on the cover page(s) hereto. (iii) sole power to dispose or to direct the disposition of: See Item 9 on the cover page(s) hereto. (iv) shared power to dispose or to direct the disposition of: See Item 10 on the cover page(s) hereto.
(c)	No transaction in the Ordinary Shares of the Issuer were effected during the past sixty days by the Reporting Person.
(d)	No other person is known to the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares of the Issuer covered by this Schedule 13D.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	There are no contracts, arrangements, understandings or relationships between the Reporting Person and the Issuer.
Item 7.	Material to be Filed as Exhibits.
	Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Moalem Moshe

Signature:	/s/ Moshe Moalem
Name/Title:	Moshe Moalem
Date:	10/29/2026